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1. Introduction
Polyurethanes are a family of polymers used in a variety of biomedical applications but
mainly  in  the  cardiovascular  field  due  to  their  good  physicochemical  and  mechanical
properties  in  addition  to  a  good  biocompatibility.  Traditionally,  segmented  polyur‐
ethanes (SPUs), have been used in cardiovascular applications (Kuan et al.,  2011) as per‐
manent devices such as pacemaker leads and ventricular assisting devices; however, due
to  their  great  chemistry  versatility,  SPUs  can  also  be  tailored  to  render  biodegradable
systems  for  the  tissue  engineering  of  vascular  grafts  and  heart  valves.  Therefore  many
research work have been focused on varying the  chemical  composition to  enhance  bio‐
stability or more recently to control the biodegradability of polyurethanes depending on
specific  applications  in  the  cardiovascular  field  (Bernacca  et  al.,  2002;  Stachelek  et  al.,
2006;  Thomas et  al.,  2009;  Wang et  al.,  2009;  Hong et  al.,  2010;  Arjun et  al.,  2012;  Styan
et  al.,  2012).  In  this  way,  polyurethanes  for  biomedical  applications  can be  classified in
two main types, according their relative stability in the human body as either biostables
or  biodegradables.  In  this  chapter,  general  aspects  of  polyurethanes  chemistry  are  pre‐
sented  first  and  then,  the  various  types  of  degradations  that  can  affect  these  polymers
both  in  vivo  and  simulated  in  vitro  conditions.  Emphasis  is  also  made  on  the  mecha‐
nism of degradation under various conditions and the techniques used for following the
changes in their properties.
© 2013 Cauich-Rodríguez et al.; licensee InTech. This is an open access article distributed under the terms of
the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
2. Chemistry of polyurethanes
2.1. Synthesis of polyurethanes
Polyurethanes (PU’s) properties depend both on the method of preparation and the mono‐
mers used. In general, PU’s can be prepared in one shot process or more commonly by a two
step method, especially for the case of segmented polyurethanes (SPU’s). These materials
are thermoplastic block copolymers of the (AB)n type consisting of alternating sections of
hard segments, composed of a diisocyanate and a low molecular weight diol chain extender,
and soft segments, generally composed of various types of polyols, also called macrodiols.
In the two steps method for SPU synthesis, a prepolymer is first obtained and then chain
extended as illustrated in Figure 1. In the first step, an excess of the diisocyanate reacts with
the soft segment polyol to form the prepolymer. Here, the characteristic urethane linkages
are formed through the reaction between the isocyanate groups and the hydroxyl-terminat‐
ed end groups of the polyol. In the second step, the low molecular weight chain extender is
used to link the prepolymer segments yielding a high molecular weight polymer. During
this stage, additional urethane functional groups are formed when using a diol chain ex‐
tender whereas ureas are produced when a diamine is used.
Figure 1. Standard two-step reaction to prepare segmented poly (urethane)s and poly(urethane-urea)s
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The  properties  of  polyurethanes  as  those  shown  in  Figure  1  depend  on  the  various
types of  monomers that are used during their  manufacturing (see Table 1).  Historically,
biostable polyurethanes were first  developed by using polyether type of polyol and dif‐
ferent  aromatic  diisocyanates.  Further  developments  in  this  area  were  focused  on  the
substitution  of  the  polyether  macrodiol  by  novel  hydrocarbon,  polycarbonate  or  silox‐
ane macrodiols (Gunatillake et al.,  2003) or a combination of these which in general are
responsible  for  the flexibility  of  the  SPUs (Król,  2007).  In  addition to  the  polyol  chemi‐
cal  composition,  their  molecular  weight  and  concentration  have  an  important  effect  in
the  polyurethane  behavior.  They  can  be  incorporated  in  various  concentrations  but  up
to 50-75% of the polyol is  common.
Commercial  and experimental  polyurethanes have been synthesized by the combination
of  the  aforementioned monomers.  Poly(tetramethylene  oxide)  (PTMO) is  the  most  com‐
mon polyether in conventional medical formulations (Silvestri  et  al.,  2011).  Thus, for ex‐
ample,  the  Pellethane®  2363  80A  and  ElasthaneTM  80A  are  poly(ether-urethane)s
obtained  by  the  reaction  of  PTMO,  MDI  and  BD  monomers;  Tecoflex®  by  Thermedics
is  also  a  poly(ether-urethane)  synthesised  by  the  reaction  of  PTMO,  HMDI  and  BD
monomers  while  Biomer® is  a  poly(ether-urea-urethane)  synthesized  from PTMO,  MDI
and  ethylenediamine.  Bionate®,  Myo  LynkTM  and  Chronoflex  are  polyurethanes  pre‐
pared with polycarbonate diol.  These commercial  polyurethanes are typical  examples of
biostables polymers.
The use of vegetable raw materials containing hydroxyl groups such as starch, castor oil,
vegetable oil, natural rubber, cellulose, etc, makes possible to obtain biodegradable polyur‐
ethanes (Krol, 2007; Aranguren et al. 2012). However, ester polyol commonly used to syn‐
thesize biodegradable polyurethanes are polycaprolactone, polylactic acid and adipate
polyols. Polyethyleneglycol is a polyether which has been copolymerized with poly lactic
acid and/or polycaprolactone because its higher hydrofilicity can accelerate the biodegrada‐
tion when this is required (Guan et al., 2005b; Wang et al., 2011b).
The most frequently used diisocyanates in the synthesis of biodegradable polyurethanes for
biomedical applications are aliphatic or cycloaliphatic as MDI and TDI which can release
carcinogenic and mutagenic aromatic diamines (Heijkants et. al., 2005). Aliphatic diisocya‐
nates are less reactive than the aromatic counterparts but have a greater resistance to hydrol‐
ysis compared to aromatic diisocyanates, although this resistance frequently results in lower
mechanical properties (Gogolewski, 1989).
In general, there are two types of compounds that are generally used as chain extenders, di‐
ols or diamines, which can either be aliphatic or aromatic, depending on the required prop‐
erties in the synthesized polyurethanes. New chain extenders, including amino acids have
been also used during polyurethane synthesis as isocyanates can react vigorously with
amine, alcohol, and carboxylic acids (Thomson, 2005). These novel chain extenders have
been used to synthesize biodegradable polyurethanes (Skarja et al., 1998; Marcos-Fernández
et al., 2006; Sarkar et al., 2007).
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Monomeric
component Type Chemical compound Type of polyurethanes
Polyol
(macrodiols)
Polyethers
Poly(ethylene oxide) (PEO) Biostables, Biodegradables (Sarkar et al., 2009; Luet al., 2012)
Poly(propylen oxide) (PPO) Biostables, Biodegradables (Francolini et al., 2011)
Poly(tetramethylene oxide)
(PTMO) Biostables (Silvestri et al., 2011; Jiang et al., 2012)
Poly(caprolactone) (PCL) Biodegradables (Sarkar et al., 2009; Lu et al., 2012)
Poly(lactic acid) (PLA) Biodegradable (Wang et al., 2011a)
Poly hydroxyalkanoates (PHA) Biodegradables (Li et al., 2009; Liu et al., 2009)
Poly(ethylene adipate) (PEA) Biodegradables (Macocinschi et al., 2009)
Others
Poly(carbonate) (PCU) Biostables (Spirkova et al., 2011)
Polybutadiene (PBD) Biostables (Thomas et al., 2009)
Poly(dimethylsiloxane) (PDMS) Biostables (Park et al., 1999; Madhavan et al., 2006)
Diisocyanate
Aromatic
Methylene diphenyl
diisocyanate (MDI)
Biostables (Gunatillake et al., 1992; Styan et al.,
2012)
2,4-toluene diisocyanate (TDI) Biostables (Labow et al., 1996; Basak et al., 2012)
Aliphatic
4,4′-methylene bis(cyclohexyl
isocyanate) (HMDI)
Biostables, Biodegradables (Thomas et al., 2009;
Chan-Chan et al., 2010)
1,6- hexamethylene
diisocyanate (HDI)
Biostables, Biodegradables (Wang et al., 2011a;
Baudis et al., 2012)
1,4-butane diisocyanate (BDI) Biostables, Biodegradables (Heijkants et al., 2005;Hong et al., 2010)
Isophorone diisocyanate (IPDI) Biostables, Biodegradables (Jiang et al., 2007; Dinget al., 2012; He et al., 2012)
L-lysine ethyl ester diisocyanate
(LDI)
Biodegradable (Abraham et al., 2006; Guelcher et
al., 2008; Han et al., 2009; Wang et al., 2011b)
Chain
Extender
Diols
Ethylene glycol (EG)
Biostables, Biodegradables (Król, 2007)
Diethylenglycol
1,4-butanediol (BD)
1,6-hexanediol (HD)
Diamines Aliphatic diaminesAromatic diamines
Others Amino acids
Biodegradables (Kartvelishvili et al., 1997; Skarja et
al., 1998; Marcos-Fernández et al., 2006; Sarkar et
al., 2007; Chan-Chan et al., 2012)
Table 1. Common monomers used in the synthesis of biostable and biodegradable polyurethanes
During polyurethane synthesis, several side reactions may occur leading to branching,
crosslinking, or changes in the stoichiometry of reactants. For example, undesirable branch‐
ing and crosslinking may occur at elevated temperatures between isocyanates and urethanes
(Allophanate formation) and isocyanates and ureas (Biuret reactions). Furthermore, the
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presence of water causes isocyanate groups to form unstable carbamic acids, which subse‐
quently decompose to amines with the liberation of CO2 gas (see Figure 2). These newly
formed amines react with isocyanates to form ureas, thus changing reactant stoichiometry
and leading to lower molecular weight polymers. Additives are sometime used for improv‐
ing specific properties of the polyurethane, for example Vitamin E and Santowhite®, two
hindered phenolic antioxidants, prevents oxidative chain scission and crosslinking of
poly(ether urethane) by capturing oxygen radicals (Schubert et al., 1997; Christenson et al.,
2006). Di-tert-butylphenol and bisphosphonates have been incorporated to promote bro‐
moalkylation of urethane nitrogens in prepolimerized polyurethanes to inhibit the oxidation
or calcification (Alferiev et al., 2001; Stachelek et al., 2007). Other compounds as fluorocar‐
bon or polydimethylsiloxane end groups have been attached to the surface of polyurethanes
in order to enhance their biostability and hemocompatibility (Ward et al., 2007; Xie et al.,
2009; Jiang et al., 2012).
In general, monomer type and stoichiometry, type and concentration of catalyzer, tempera‐
ture and moisture, and the use of additives are important in parameters for controlling the
properties of these polymers.
Figure 2. Secondary reactions involved during polyurethane synthesis
3. In vivo degradation
SPU´s traditionally has been used in medical devices due to their excellent mechanical prop‐
erties and an acceptable hemocompatibility. However, in the long term they suffer from
poor biostability (Santerre et al., 2005). The main reason of this behavior is that living tissues
are a very aggressive environment and even when the degradation of these polymers can be
simulated by in vitro experiments, after in vivo usage they can be severally degraded. The in
vivo failure of polymeric cardiovascular devices has been attributed to a combination of hy‐
drolysis, oxidation, environmental stress cracking and calcification. However, depending on
the composition of the polymer one of these predominate over the other.
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Polymer degradation in the biological environment results from the synergistic effects of
the enzymes present in biological fluids,  oxidizing agents and mechanical loads. For ex‐
ample,  α-2-macroglobulin,  cholesteryl  esterase,  A2  fosfolipase,  K  protease  and B  Cathe‐
psin are enzymes that are known to degrade polyurethanes (Zhao et al.,  1993; Dumitriu,
2002).  Even  when  some  enzymes  require  very  specific  biological  substrates,  some  of
them  seem  to  recognise  and  act  over  non  biological  substrates  such  as  polymers  (San‐
terre et  al.,  2005).  White  blood cells  play also an important  role  in the in  vivo  degrada‐
tion.  Some  experiments  conducted  using  implanted  metallic  cages  have  shown  that
neutrophiles,  monocytes,  monocyte derived macrophages (MDM) attach to polymer sur‐
faces,  leading to the presence of multinucleated giant cells and foreign body reaction. It
is  generally  accepted  that  one  of  the  immediate  immune  responses  by  the  body  is  the
release of reactive oxygen species (ROS). In addition, neutrophils and monocytes release
hypochlorous acid (HClO) and lysosomal hydrolases as part  of  their  reaction to foreign
surfaces.  It  has  been also  reported that  activated MDM release  ROS leading to  the  for‐
mation of hydrogen peroxide (Christenson et al.,  2006; McBane et al.,  2007).  In addition,
during the  inflammatory reaction macrophages  are  able  to  lower  the  local  pH up to  4.
This condition can be simulated by following the ISO 10993 section 5.
Suntherland  et  al.  (Sutherland  et  al.,  1993)  suggested  that  poly(ether  urethanes)  (PEU)
cannot be significantly degraded by preformed products of phagocytic cells (such as cat‐
ionic proteins and proteases) or by activated oxygen species such as superoxide and hy‐
drogen peroxide. In view of the chemically stable nature of PEU, they hypothesized that
the in vivo  degradation of these materials might involve attack by chlorine-based and/or
nitric  oxide  (NO)-derived  oxidants,  major  oxidative  products  of  activated  phagocytes.
Therefore,  they  exposed  Pellethane  to  polymorphonuclear  neutrophils  (PMN)  isolated
from heparinized venous  blood drawn from normal  adult  donors.  The  results  reported
support the idea that PMN-generated chlorine compounds are likely responsible for ini‐
tial  damage to PEU after brief  implantation and in addition to macrophage-derived NO
and/or peroxynitrite (ONOO-).
Van Minen et al. (van Minnen et al., 2008) studied the in vivo (26 weeks of subcutaneous im‐
plantation in rats and 2.5 years in rabbits) degradation of porous aliphatic SPU based on bu‐
tanediisocyanate, DL-lactide-co-caprolactone soft segments and extended with BD-BDI-BD
block urethane. After 1 week macrophages were observed along with giant cells and after 4
week phagocytosis was observed. The number of these cells was reduced with time but after
3 years fragments of the polymer remained. Furthermore, few macrophages were observed
in the lymph nodes suggesting their local degradation.
Adhikari et al. (Adhikari et al.,  2008) studied the in vivo  degradation of two-part injecta‐
ble biodegradable polyurethane prepolymer systems (prepolymer A and B) consisting of
lactic  acid and glycolic  acid based polyester  star  polyols,  pentaerythritol  (PE)  and ethyl
lysine  diisocyanate  (ELDI)  using sheep femoral  cortical  defect  model.  No adverse  acute
or  chronic  inflammatory  tissue  response  was  noted  in  the  interface  tissues  of  the  pre‐
cured  polymer  implants.  By  6  weeks,  there  was  direct  apposition  of  new  bone  to  the
polymers.  New  bone  and  fibrovascular  tissue  was  also  observed  within  the  porous
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spaces of  the precured polymers by 6  weeks,  and fluorochrome analysis  suggested that
this bone had started to be laid down at between 4 and 5 weeks.  The polymer without
β-tricalcium  phosphate  (TCP)  showed  histological  evidence  of  some  degradation  by  6
weeks with progressive increase in polymer loss by 12 and 24 weeks. The polymer with
β-TCP  showed  no  evidence  of  degradation  at  6  weeks  and  only  minimal  loss  at  12
weeks.  By  12  weeks,  there  had  been  considerable  degradation  of  the  polymers  and  at
week 24, polymer was completely degraded.
The in vivo degradation of segmented poly(urethane urea)s (SPUUs) with hard segments de‐
rived only from methyl 2,6-diisocyantohexanoate (LDI) and PCL, PTMC (polytrimethylene
carbonate), P(TMC-co-CL), P(CL-co-DLLA), or P(TMC-co-DLLA) as soft segment was con‐
ducted by Asplund et al. (Asplund et al., 2008). The in vivo study of SPUU-PCL using male
Sprague-Dawley rats displayed the typical foreign body response seen with most inert poly‐
meric implant materials. The reaction at 1 week thus displayed an infiltration of ED1 posi‐
tive macrophages closest to the implant surface, an outside layer of fibroblasts and some
collagen formation. At 6 weeks, the foreign body capsule had matured, displaying lower
numbers of interfacial macrophages and an increased amount of collagen in the fibrotic cap‐
sule. The thickness of the foreign body capsule was similar to the controls. These observa‐
tions seemed also to be reflected in the number of ED1 positive macrophages, as well as in
the total number of cells throughout the reactive capsule.
Hafeman et al. (Hafeman et al., 2008) synthesized polyurethane scaffolds by one-shot reac‐
tive liquid molding of hexamethylene diisocyanate trimer (HDIt) or lysine triisocyanate
(LTI) and a polyol as hardener. Trifunctional polyester polyols of 900-Da and 1,800-Da mo‐
lecular weight were prepared from a glycerol starter and 60% ε-caprolactone, 30% glycolide,
and 10% D,L-lactide monomers, and stannous octoate catalyst. Tissue response was evaluat‐
ed by subcutaneous implantation in male Sprague-Dawley rats for up to 21 days. During
this time, initial infiltration of plasma progressed to the formation of dense granulation tis‐
sue. All of the implants showed progressive invasion of granulation tissue with little evi‐
dence of an overt inflammatory response or cytotoxicity. Fibroplasia and angiogenesis
appeared to be equivalent among the different formulations. Extracellular matrix with dense
collagen fibers progressively replaced the characteristic, early cellular response. The LTI
scaffolds exhibited a greater extent of degradation at 21 days, although the incorporation of
PEG into the HDIt scaffold accelerated its degradation significantly. Degradation rates were
much higher in vivo. With time, each of the materials showed signs of fragmentation and en‐
gulfment by a transient, giant cell, foreign body response. After the remnant material was
resorbed, giant cells were no longer evident.
Khouw et al. (Khouw et al., 2000) reported that the foreign body response to degradable ma‐
terials differs between rats and mice. van Minnen et al., (van Minnen et al., 2008) also sug‐
gested that it is possible that the response between rats and rabbits differs as well, due to the
faster degradation in the rabbit. This may be related to differences at the enzymatic or cellu‐
lar level, but also to the highly mobile and well vascularized skin of the rabbit, as compared
to the rat.
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3.1. Calcification
Mineralization or calcification (formation of various types of calcium phosphates such as
apatite) is a well documented event in various medical devices, especially in those used
in the cardiovascular field. Calcification is in fact, the most common macroscopic cause of
failure in heart valves including those made of polyurethanes (Santerre et al., 2005). Even
when  calcification  has  been  identified  in  heart  valves,  in  vitro  experiments  on  SPU
showed little mineralization and associated exclusively to failure regions,  indicating that
the SPU´s have a lower intrinsic capacity for calcification compared to bovine bioprosthe‐
sis (Bernacca et al., 1997).
3.2. Thrombosis
Plasma  protein  adsorption  is  well  accepted  as  one  of  the  first  events  to  occur  when
blood  is  in  contacts  with  a  biomaterial.  These  adsorbed  proteins  mediate  the  subse‐
quent interactions of  cells  and platelets  with the surface and may induce thrombus for‐
mation,  which remains one of  the major  problems associated with the long-term use of
blood-contacting medical  devices.  The surface  properties  of  the  implanted materials  are
determinant  in  protein  adsorption and biological  interactions  with  the  material.  The  ef‐
fects  of  various physicochemical  properties  such as  surface hydrophilicity/hydrophobici‐
ty  balance,  surface  charge  density,  ability  to  form  hydrogen  bonds,  and  chemical
composition  of  biomaterials  on  protein  adsorption  as  well  as  subsequent  blood platelet
adhesion have been investigated (Xu et  al.,  2010).
Antithrombogenicity  is  one  of  the  essential  requirements  for  a  vascular  graft,  but  it  is
very  difficult  to  achieve.  There  are  two  common  approaches  employed  to  attain  this
goal.  One  is  to  develop  biomaterials  with  inherent  antithrombogenicity  or  to  use  sur‐
face modified biomaterials  with an anticoagulant.  The other  approach is  to  quickly and
completely  endothelialize  the  inner  surface  of  the  tubular  scaffolds,  thereby,  reducing
thrombogenicity (Yan et  al.,  2007).
Thrombosis  is  a  leading  cause  of  vascular  graft  failure  in  small-diameter  prostheses,
where  it  leads  to  decreased  flow  or  occlusion.  In  addition  to  inducing  acute  or  suba‐
cute  failure  of  grafts,  it  may  be  a  cause  of  late  failure  owing  to  thrombosis  superim‐
posed on stenosis  due to other causes of  vessel  narrowing,  such as intimal hyperplasia.
Methods  to  improve  vascular  grafts  (e.g.,  antithrombotic  therapy)  have  been  shown  to
be  beneficial  in  decreasing  graft  occlusion  after  surgery.  Agents  known  to  inhibit
thrombogenesis  or  promote anticoagulation (e.g.,  heparin,  prostaglandin E1,  hirudin,  di‐
pyridamole,  tissue  factor  pathway  inhibitor  and  aspirin)  have  also  been  bound  to  the
lumen of the synthetic vessels (Wang et  al.,  2007;  Lu et  al.,  2012).
3.3. Environmental stress cracking and metal ion oxidation
Traditionally, SPUs have been used as permanent devices such as pacemaker leads insula‐
tion and ventricular assisting devices. When used as pacemaker lead insulators, they substi‐
tute silicone rubbers and have been used as biostable polymer for outer or inner insulated
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coating of coaxial bipolar pacemakers. Unfortunately, decades of experience showed that
they were degraded by environmental stress cracking (ESC) or metal ion oxidation (MIO) or
even autooxidation (AO) within a period of 28 and 34 months.
Environmental stress cracking includes crack formation and propagation on the surface of
the polyurethane (Santerre et al., 2005). However, this type of degradation is a combination
of the in vivo chemical degradation with the presence of mechanical stresses. In other words,
polymer chain scission caused by the chemical degradation, create microscopic defects that
are augmented by the presence of mechanical loads, leading to the formation of cracks on
the surface (Wiggins et al., 2003). ESC it is also enhanced by the presence of residual stresses
in the polymeric surface introduced during manufacturing and not eliminated during poly‐
mer annealing (Santerre et al., 2005).
The generally accepted in vivo degradation MIO mechanism involves the presence of hydro‐
gen peroxide (H2O2) produced by a variety of inflammatory cells (McBane et al., 2007; Chan‐
dy et al., 2009) and divalent metal ion such as Co2+ released from the lead. This reaction is
known as the Haber-Weiss reaction and yields hydroxyl radicals that can attack α-methyl‐
ene groups in the polyether (PTMO based polyurethanes) to render hydroperoxydes with
decompose in the presence of divalent cations rendering carbonyl groups that can accelerate
(catalyse) further this decomposition (Kehrer, 2000; Wiggins et al., 2001). Polyether diol
based polyurethanes are prone to oxidation and environmental stress cracking (ESC) (Król,
2007). However, polycarbonate based-polyurethanes (PCNUs) have been proven superior to
polyether and polyester PUs, especially in terms of reduced ESC and metal ion oxidation
(MIO), although they are still susceptible to hydrolysis (McBane et al., 2007).
Environmental  stress  cracking,  calcification and thrombosis  only  became evident  after  a
sufficiently  long-term  implantation  of  several  years.  For  biodegradable  PUs,  which  are
designed  to  degrade  in  a  relative  short  period  (several  months),  the  effective  degrada‐
tion  mechanisms  are  hydrolysis  with  or  without  the  assistance  of  enzymatic  catalysis
(Chen et  al.,  2012).
4. In vitro degradation to simulate in vivo degradation
In vivo experimentation using an animal model is not always available for elucidating the
degradation mechanism of polyurethanes. Instead, various in vitro experiments have been
designed to simulate their in vivo degradation. Among these tests, hydrolytic degradation
has been conducted using distilled water (at elevated temperature), strong acids and alka‐
lies, and sometimes physiological conditions using Phosphate Buffer Saline (PBS) as degra‐
dating media.
4.1. Hydrolytic degradation
Degradation of segmented polyurethanes through hydrolysis depends strongly not only on
the chemical composition of the soft segment, when is the major component, but also on the
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rigid segment chemistry. It is generally accepted that water absorption is a necessary condi‐
tion for hydrolytic degradation of materials. Therefore, in a typical hydrolytic degradation
test the rate of water absorption (or sample weight gain) can be correlated with sample
weight loss (Mondal et al., 2012).
The presence of labile ester linkages in PCL containing polyurethanes makes them suscepti‐
ble to degradation in the presence of water (Gunatillake et al., 1992; Nakajima-Kambe et al.,
1999; Kannan et al., 2006). This type of reactions is catalysed by the presence of acids or alka‐
line compounds. In some cases, the acid is produced by the degradation of the soft segment;
caproic acid in the case of PCL or lactic acid in the case of PLA. Polyester urethanes are more
prone to hydrolytic degradation although they are more resistant to oxidative environments
as can be observed in Table 2, where PCL based polyurethanes (BSPU1 and BSPU2) and a
commercial polyether polyurethane (Tecoflex) are compared (Chan-Chan et al., 2010).
H2O NaOH 5M HCl 2N H2O2 30 wt.%
BSPU1* 1.46 ± 0.08 63.42 ± 7.63 82.70 ± 2.60 13.08 ± 3.35
BSPU2* 6.15 ± 1.35 87.23 ± 4.76 52.65 ± 13.26 19.07 ± 7.01
Tecoflex 0.63 ± 0.3 1.66 ± 0.66 1.48 ± 1.62 2.16 ± 1.47
* BSPU’s were prepared with PCL, HMDI and either butanediol (BSPU1) or dithioerythritol (BSPU2) as chain extenders.
Table 2. Polyurethane mass loss (%) after degradation under hydrolytic and oxidative accelerated conditions
Because of the susceptibility of the ester groups to hydrolysis, biodegradable poly(ester ure‐
thanes) degrade in vitro through bulk erosion via chain scission. During hydrolysis, new car‐
boxylic acid groups are formed that auto-catalyze the degradation, leading to faster
degradation in the bulk than at the surface. Thus, a decrease in molecular weight preceding
the loss of mechanical properties and weight loss is typical for such degradation. In addi‐
tion, an increase in crystallinity is observed, if the soft segment contains a crystalline frac‐
tion. Polyesters in the soft segment will, therefore, increase the effect of hydrolysis
compared with polyether or polycarbonates (Ma et al., 2012).
Tanzi et al. (Tanzi et al., 1991) degraded various commercial polyurethanes used in the car‐
diovascular field among them Cardiothane 51, Pellethane 2363 80A, Estane 5714 Fl, Estane
58810 and Biomer. The degradation was conducted in water or alkaline borate buffer (pH
10) at 37˚C, 60˚C and 85˚C from 96 h to 168 h. They found that after hydrolytic degradation
in distilled water at 85˚C for 96 h, borate buffer during 96 h at 60˚C and borate buffer during
168 h at 37˚C there were no changes in tensile properties although a reduction in molecular
weight was reported.
Polyester urethanes based on methylene-bis(4-phenylisocyanate) (MDI), BD and polyadi‐
pate diol were prepared by Pretsch (Pretsch et al., 2009) and accelerated degradation studied
in distilled water at 80˚C where the degradation process was followed by DSC. It was found
that the intensities of the melting peaks and therefore the crystallinity of the soft segments
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increase after one day. Then, two main degradation scenarios were proposed: first, a hydro‐
lytic scission of polymer chains in the molten soft segments take place, which is accelerated
by the ‘‘high’’ immersion temperature; second, and on top of it, there is an annealing effect.
For example, the domains of segmented polyurethane elastomers may become unstable at
high temperatures and mixing of hard and soft segments is enforced.
Wang et al. (Wang et al., 2011a) prepared segmented polyurethanes based on poly(D,L-lactic
acid)diol, hexamethylene diisocyanate (HDI) and with either peperazine (SPU-P), 1,4-buta‐
nediol (SPU-O) or 1,4-butanediamine (SPU-A) as chain extenders. The degradation process
was conducted in double distilled water at 37˚C and 50 rpm. For these SPUs, acidic groups
from the degradation of PDLLA and BD could reduce the pH value of medium, while the
dissolution of the hard segment (amide group and carbamide) could alkalize the medium;
after 12 weeks, the pH values of SPU-O, SPU-A and SPU-P were 2.57, 3.87 and 3.71, respec‐
tively. These results suggest that the chain extender can play a main role in the degradation
mechanism as using an alkaline chain extender can neutralize the acidity, the hydrophilicity
and hydrolysis sensitivity of these bonds.
4.2. Oxidative degradation
Polyether urethanes (PEU) are readily degraded by oxidative conditions (Stachelek et al.,
2006). Furthermore, the presence of metallic ions such as cobalt accelerates this process (Gu‐
natillake et al., 1992; Dumitriu, 2002; Santerre et al., 2005). The MIO mechanism was repro‐
duced in vitro by immersing a lead into a hydrogen peroxide solution. In a different in vitro
test, a sealed PEU tube containing cobalt metal in the center was immersed into a 3% hydro‐
gen peroxide solution and MIO was observed on the inner surface of the tube. The cobalt
ion and hydrogen peroxide react to form hydroxyl radicals, simulating the oxidative radi‐
cals present at the material-macrophage interface.
Takahara et al. (Takahara et al., 1991) degraded SPU´s based on MDI, BD (50% rigid seg‐
ment content) and various polyols using 0.1 M AgNO3 oxidative solution. They found a re‐
duction in mechanical strength of those SPU´s based on PTMO due to surface cracking
related to ether scission upon oxidation.
Suntherland et al. (Sutherland et al., 1993) degraded Pellethane 2363 80A using 10 mM
HClO in phosphate buffer (PB) at 25°C. In addition, peroxynitrite (ONOO-) degradation
was achieved via the oxidation of hydroxylamine in an oxygen atmosphere at elevated pH.
They observed a significant reduction in molecular weight, increase in polydispersity index
and an increasing content of oxygenated species on the polymer surface.
Tanzi et al. (Tanzi et al., 2000) studied the oxidative degradation of polyether (Pellethane
2363 80A) and polycarbonate (Corethane 80A, Bionate 80A and Chronoflex AL 80A) ure‐
thanes in 0.5 N nitric acid (acidic) and sodium hypochlorite (4% Cl2, alkaline) up to 14 days
at 50˚C and under constant strain (100%). It was found that PEU were more degraded under
alkaline oxidation (HClO) mainly in the absence of applied strain while PCU was more af‐
fected by HNO3.
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Our  own  work  using  Tecoflex  as  model  PEU  degraded  in  H2O2  did  not  show  signifi‐
cant  changes  in  FTIR  absorptions  and  only  small  differences  in  the  bands  located  at
3330 cm-1  and 1660 cm-1  were observed (see Figure 3),  although this was clear when the
polyol  was  tested  alone.  However,  TGA  revealed  that  their  degradation  temperature
were  lowered  and  the  amorphous  content  determined  by  XRD  only  exhibited  a  little
changes (Chan-Chan et  al.,  2010).
Figure 3. Chemical and structural changes in Tecoflex after degradation under oxidative conditions
4.3. Degradation in physiological media
Poly(ester urethane)urea (PEUU) and poly(ether ester urethane)urea (PEEUU) from poly‐
caprolactone, polycaprolactone-b-polyethylene glycol-b-polycaprolactone, BDI and putres‐
cine were prepared by Guan et al. (Guan et al., 2005a) and degraded in phosphate buffered
saline (PBS, pH=7.4) at 37˚C; scaffold degradation was related to the porosity and polymer
hydrophilicity. The scaffolds exhibited progressive mass loss over the 8-week period rang‐
ing from 13.3% to 20.7% for PEUU scaffolds and from 25.4% to 47.3% for PEEUU scaffolds.
In this study, the polymer films and scaffolds did not show evidence of an autocatalytic ef‐
fect during the monitored degradation process. Furthermore, the presence of BDI and 1,4-
butanediamine in the hard segment of PU yielded putrescine as degradation product, which
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is already present in the body and has been implicated as an important mediator of cellular
growth and differentiation in response to growth factors.
Two gelatin based poly(ester urethane) were prepared by Sarkar et al. (Sarkar et al., 2006)
using polyethylene lactate ester diol as a soft segment, and degraded in phosphate buffer
saline solution (pH 7.4) at 37°C in a Biochemical Oxygen Demand (BOD) incubator shaker. It
was found that the weight loss (up to 45.7% in 30 days) occurred due to the hydrolytic deg‐
radation of the gelatin based polyester urethane scaffold by PBS solution and it was propor‐
tional to the gelatin content.
Sarkar et al. (Sarkar et al., 2008) prepared segmented polyurethanes using polyethylene gly‐
col (PEG) or poly caprolactone diol (PCL) as the soft segment while hexamethylene diiso‐
cyanate (HDI) or dicyclohexylmethane 4,4-diisocyanate (HMDI) were used with
desaminotyrosyl tyrosine hexyl ester (DTH) as the chain extender in the rigid component.
For degradation in PBS (0.1M, pH 7.4 containing 200 mg of sodium azide) samples were in‐
cubated at 37˚C. It was found that PEG-based polyurethanes degrade at a faster rate com‐
pared with PCL-based polyurethanes due to their hidrophillicity and that this effect was
marked when using high molecular weight PEG. It was also found that more amorphous
SPU (i.e. exhibiting more phase mixing and therefore more urethane linkages H-bonded
with the soft segment), such as those prepared with HMDI, degrade faster as they absorb
more water.
Knight et al. (Knight et al., 2008) studied new hybrid thermoplastic polyurethane (TPU) sys‐
tem that incorporates an organic, biodegradable poly(D,L-lactide) soft block with a hard
block bearing the inorganic polyhedral oligosilsesquioxane (POSS) moiety and degraded
them in PBS buffer at 37 °C over a 2 months period. They found that less than 4% of the
original mass elutes from the sample after a month in the buffer, most likely from chain
ends on the surface of the sample undergoing hydrolysis. Although only a small mass loss
was observed, the molecular weight of the samples dropped dramatically after only one
week to 40% of the initial molecular weight.
Biodegradable ionic polyurethanes (PUs) were synthesized from methylene di-p-phenyl-dii‐
socyanate (MDI), polycaprolactone diol (PCL-diol) and N,N-bis (2-hydroxyethyl)-2-amino‐
ethane-sulfonic acid (BES) by Zhang et al. (Zhang et al., 2008). In vitro degradation of the
PUs was evaluated by recording the samples’ weight loss, molecular weight changes, and
mechanical properties changes over time in PBS buffer solution at 67°C to accelerate degra‐
dation. Although there was a 20% molecular weight reduction, degradation rate was lower
in those PUs containing sulfonic acid compared to PU´s without this chain extender. This
was explained in terms of their higher phase separation.
Segmented polyurethane based on poly(ε-caprolactone), ethyl lysine diisocyanate or hexam‐
ethylene diisocyanate in combination with ethylene glycol or ester from ethylene glycol and
lactic acid (2-hydroxyethyl 2-hydroxypropanoate) were degraded in vitro (0.1 M phosphate
buffered saline at 37°C in a shaken incubator set at 50 rpm (ASTM F 1635)) over a 1 year
period (Zhang et al., 2008). It was found that all polyurethanes exhibited considerable mo‐
lecular weight decrease over the test period and ester chain extender polyurethanes showed
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the highest mass loss and that it was directly proportional to hard segment not to the PCL
used as soft segment.
Guelcher et al. (Guelcher et al., 2008) prepared injectable polyurethanes by two-component
reactive liquid molding of low-viscosity quasi-prepolymers derived from lysine polyisocya‐
nates and poly(3-caprolactone-co-DL-lactide-co-glycolide) triols and degraded porous discs
by incubation in PBS at 37˚C and 5% CO2 for 2, 4, 6, and 8 months. They found that these
polymers degrade by hydrolysis of ester linkages to yield α-hydroxy acids and soluble ure‐
thane fragments. Furthermore, the materials prepared from PCL triol exhibit minimal (e.g.,
<5%) degradation after 8 months. However, materials prepared from P6C3G1L (triol synthe‐
sized from a glycerol starter and a mixture of monomers comprising 60% caprolactone, 30%
glycolide, and 10% DL-lactide) exhibit 15-27% mass loss after 8 months.
Multi-block poly(ether ester urethane)s consisting of poly[(R)-3-hydroxybutyrate] (PHB),
poly(propylene glycol) (PPG), and poly(ethylene glycol) (PEG) were prepared by Loh et al.
(Loh et al., 2007). The poly(PEG/PPG/PHB urethane) copolymer hydrogels were hydrolyti‐
cally degraded in phosphate buffer at pH 7.4 and 37°C for a period of up to 6 months. The
degradation products in the buffer were characterized by GPC, 1H NMR, MALDI-TOF, and
TGA. The results showed that the ester backbone bonds of the PHB segments were broken
by random chain scission, resulting in a decrease in the molecular weight. In addition, the
constituents of degradation products were found to be 3-hydroxybutyric acid monomer and
oligomers of various lengths (n= 1–5).
Multiblock poly(ether ester urethane)s comprising of poly(lactic acid) (PLA), poly(ethylene
glycol) (PEG), and poly(propylene glycol) (PPG) segments and hexamethylene diisocyanate
were synthesized by Loh et al. (Loh et al., 2008). Their degradation process in pH 7.4 buffer
solution (8.0 g of NaCl, 0.2 g of KCl, 1.44 g of Na2HPO4, and 0.24 g of K2H2PO4 in 1 L of solu‐
tion) was studied over a period of 3 months. Multi-modal GPC profiles of these polymers
suggested that the polymer degrades in fragments with molecular weight of about 2000,
4000, 6000 and 8000 g/mol. These gels degraded at a much faster rate than the previously
reported PEG-PPG-PHB poly(ester urethane) thermogels, which were reported to degrade
over a period of 6 months.
Degradation of segmented poly(urethane urea)s (SPUUs) with hard segments derived only
from methyl 2,6-diisocyanatehexanoate (LDI) and PCL, PTMC, P(TMC-co-CL), P(CL-co-
DLLA) or P(TMC-co-DLLA) as soft segment was conducted by Asplund et al. (Asplund et
al., 2008). For the hydrolysis study, sterile and nonsterile samples were placed in 40 mL PBS
buffer solution (pH 7.4) and put in an oven at 37˚C. Degradation was studied after 5, 10, 15,
and 20 weeks and analyses performed in triplicate for each sample. The effect of sterilization
was studied after 10 weeks of hydrolysis. Physical ageing was studied after 5 and 15 weeks
at 50˚C. They found that the degradation rate was dependant on the soft segment structure,
with a higher rate of degradation for the polyester-dominating PUUs exhibiting a substan‐
tial reduction in intrinsic viscosity. A tendency of reduction of tensile strength and strain
hardening was seen for all samples. Also, loss in elongation at break was detected, for PUU-
P(CL-DLLA) it went from 1600% to 830% in 10 weeks. Gamma radiation caused an initial
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loss in inherent viscosity and induced more rapid hydrolysis compared with nonsterilized
samples, except for PUU-PTMC.
Yeganeh et al. (Yeganeh et al., 2007) prepared epoxy terminated polyurethanes from glyci‐
dol and isocyanate-terminated polyurethanes made from poly(ε-caprolactone) (PCL) or
poly(ethylene glycol) (PEG) and 1,6-hexamethylene diisocyanate. Degradation studies were
performed using tris buffered saline solutions (TBS; 0.05, 0.1molL−1 NaCl, pH 7.4) and incu‐
bated at 37°C up to 6 months. They observed that degradation rates correspond to their wa‐
ter-absorbing ability, with faster degradation in the more absorbent polymers while the
weight loss, due to hydrolytic degradation, increased as the amount of PEG content in‐
creased. A possible explanation is that following dissolution of some PEG segments, there
will be an increase in the porosity of the blends, leading to a greater surface area for water to
access the ester bonds of hydrophobic PCL, which dominates the degradation rate. Other
possible explanations include an increase in the hydrophilicity of the surface, which acceler‐
ates degradation, or an increase in the mobility of the PCL molecules, which could also facil‐
itate hydrolytic degradation. Also the rate of hydrolysis was raised with increasing time,
which might result from the augmentation content of hydrophilic hydroxyl, amine, and car‐
boxylic groups generated at the surface during degradation.
Wang et al. (Wang et al., 2008) prepared novel biodegradable and biocompatible poly(ester-
urethane)s by in situ homogeneous solution polymerization of poly(3-caprolactone) diol, di‐
methylolpropionic acid (DMPA), and methylene diphenyl diisocyanate in acetone followed
by solvent exchange with water. The hydrolytic degradation test was conducted on buffer
solution (pH=7.4) at 37˚C up to 12 weeks and showed that the degradation rate was little
affected by the DMPA content in the range investigated, but was observed to be influenced
by the hard segment content.
Hong et al. (Hong et al., 2010) synthesized poly(ester carbonate)urethane ureas (PECUUs)
using a blended soft segment of poly(caprolactone) (PCL) and poly(1,6-hexamethylene car‐
bonate) (PHC), 1,4- butane diisocyanate and putrescine as chain extender. They found that
degradation of PECUUs in aqueous buffer (PBS at 37˚C) and subcutaneous implantation in
rats (Adult female Lewis rats) was slower than poly(ester urethane)urea but faster than
poly(carbonate urethane)urea (PCUU). Over a period of 56 days, poly(ether urethane)ureas
(PEUU) exhibited a 9% mass loss in addition to a reduction in inherent viscosity, while all of
the PECUUs and PCUU did not show detectable loss of mass. In vivo it was observed that
the majority of the PEUU scaffold was degraded, and loose connective tissue occupied the
implant area with few observed putative macrophages. For the PECUU 50/50 scaffolds,
more remnant material was seen with darker violet staining of the putative infiltrating mac‐
rophages and fibroblasts.
Chan-Chan et al. (Chan-Chan, et al. 2012) synthesized new polyester poly(urethane-urea)s
and their molecular weight changes during PBS degradation were monitored by gel perme‐
ation cromatography (GPC) (see Figure 4). Significant weight loss was not observed at six
months but bulk degradation was corroborated by this analytical technique.
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Figure 4. Molecular weight reduction in polyurethanes based on butanediamine (PUBDA), arginine (PUR), glycine
(PUG) and aspartic acid (PUD).
4.4. Enzymatic degradation
Huang et al. (Huang et al., 1979) reported that a low molecular weight poly(ester-urea),
poly(L-phenyl alanine/ethylene glycol/1,6-hexane diisocyanate), and a model diesterdiurea,
dimethyl diphenyl alanine hexamethylene urea, were hydrolyzed by chymotrypsin at pH 8.
They also observed degradation with papain latex (pH 6.5, PBS) of the model diesterdiurea.
Takahara et al. (Takahara et al., 1992) degraded SPU´s based on MDI, BD and various poly‐
ols using papain (80 U/mL) and papain activating solution (0.05 M cysteine, 0.02 EDTA,
pH=6.5 ) in sodium acetate buffer solution. In this study it was found that PEO based poly‐
urethanes exhibited the larger mass loss from all the SPU´s studied in addition to a reduc‐
tion in Young´s modulus and tensile strength due to a reduction in molecular weight.
Labow et al. (Labow et al., 1996) degraded in elastase (from human neutrophils or pancreat‐
ic porcine) a poly(ester-urea-urethane) containing [14C]toluene diisocyanate (TDI), poly(cap‐
rolactone) and ethylenediamine as well as a poly(ether-urea-urethane) containing [14C]TDI,
poly(tetramethylene oxide) and ethylenediamine (ED). They used neutrophils, which con‐
tain elastolytic activity, as they are present during the inflammatory response. Ten-fold
more radioactive carbon was released when porcine pancreatic elastase was incubated with
[14C]TDI/PCL/ED than when human neutrophil elastase was used. Ten-fold less radioactive
carbon was released when [14C]TDI/PTMO/ED was incubated with porcine pancreatic elas‐
tase (PPE) as compared to [14C]TDI/PCL/ED. Radioactive carbon release data for
[14C]TDI/PCL/ED polymer incubated with trypsin, a possible contaminant in pancreatic por‐
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cine elastase showed no significant release of radioactive carbon by the same number of
units of trypsin which would be present in the commercial PPE preparation used in the bio‐
degradation experiments.
Skarja and Woodhouse (Skarja et al., 2001) studied degradable segmented polyurethanes
containing a phenylalanine diester chain extender and degraded them in buffer chymotryp‐
sin and trypsin solutions for up to 28 days. In this study it was found that the presence of
phenylalanine resulted in an increased susceptibility to enzyme-mediated while the magni‐
tude of degradation and erosion was highly variable and was dependent on soft segment
type (PCL or PEO) and molecular weight (500-2000 g/mol).
It is well-known that the segmented poly(urethane ureas) prepared from 4,4-diphenylme‐
thane diisocyanate, oligotetramethylene glycol, and diamines are not easily hydrolyzed by
enzymes. This was further extended by Thomas and Jayabalan (Thomas et al., 2001) who re‐
ported that completely aliphatic poly(urethane urea) based on 4,4-methylene bis-cyclohexyl
isocyanate/hydroxy terminated polybutadiene/1,6-hexamethylene diamine did not degrade
in papain after 30 days at 37˚C.
Labow et al. reported that cholesterol esterase cleaved polyetherurethanes at the most prob‐
able site susceptible to hydrolytic cleavage, which is the urethane bonds, resulting in the re‐
lease of free amine (Labow et al., 2002). Santerre’s group has also reported the degradation
of polycarbonate polyurethanes with cholesterol esterase (Tang et al., 2002). Both the carbo‐
nate and urethane bonds were cleaved, resulting in many products ranging in molecular
weight from 150 to 850 g/mol, as identified by GC–MS.
Yamamoto et al. (Yamamoto et al., 2007) degraded with different thiol proteases (papain,
bromelain, and ficin) and Protease K and chymotrypsin, lysine diisocyanate (LDI) based
poly(urethanes) and segmented poly(urethane ureas). For this, 1 mg of enzyme was added
into the test tube coated with the polymer at 37˚C and the total organic carbon (TOC) meas‐
ured. From 1H NMR results, it was evident that the pendant methyl ester group in LDI was
rapidly hydrolyzed, followed by slow hydrolysis of urethane bonds in the backbone chain
while the susceptibility of urea bonds to papain was very low. Before 50 h almost 30% of the
PU has been degraded, with ethylene glycol exhibiting the highest rate of degradation; thiol
proteases were most effective for all SPUUs. LDI/PTMO (Mw=2000 g/mol)/1,3-propylendia‐
mine (PDA) (2/1/1), which does not contain degradable soft segments (caprolactone block),
showed degradation by various proteases. This fact strongly suggests that the cleavage of
the hard segment (urethane and/or urea) by these proteases occurred. For the SPUU the ex‐
pected water-soluble degradation products are diamine, α-hydroxy caproic acid, and its low
molecular oligomers, in addition to lysine derivatives.
Hafeman et al. (Hafeman et al., 2011) investigate the effects of esterolytic and oxidative con‐
ditions on scaffold degradation by incubating in 1 U/mL cholesterol esterase (CE), 1 U/mL
carboxyl esterase (CXE), and 10 U/mL lipase (L) hydrogen peroxide (20 wt% hydrogen per‐
oxide (H2O2) in 0.1 M cobalt chloride (CoCl2), and buffer alone (0.5 M monobasic sodium
phosphate buffer with 0.2% w/w sodium azide) and measured the mass loss for 10 weeks at
37˚C. Polyurethane scaffolds were prepared by one-shot reactive liquid molding of hexam‐
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Trifunctional polyester polyols of 900-Da molecular weight were prepared from a glycerol
starter and 60% ε-caprolactone, 30% glycolide, and 10% D,L-lactide monomers (6C), (t1/2 = 20
days) and 70% caprolactone, 20% glycolide, and 10% lactide (7C) (t1/2 = 225 days) and stan‐
nous octoate catalyst. Incubation with esterases slightly accelerated degradation relative to
PBS. Differences in degradation between the three candidate enzymes at any given time
point were not significant. In contrast, incubation with medium that created an oxidative
microenvironment had a more significant effect on the polyurethane degradation rate, espe‐
cially for the LTI-based materials, except the 6C/HDIt (hexamethylene diisocyanate trimer) +
PEG, which interestingly degraded faster in the presence of cholesterol and carboxyl ester‐
ase than in oxidative medium.
A new family of water borne polyurethanes (WBPU) were synthesized by Jiang et al. (Jiang
et al., 2007) using isophorone diisocyanate (IPDI), polycaprolactone (PCL), polyethylene gly‐
col (PEG) and BD:Lysine (1:1) as the chain extender. The polyurethane was then enzymati‐
cally degraded in PBS (pH = 7.4) with a solution mixture including PBS 60.0 ml, 0.1% MgC12
15.0 ml and Lipase AK (10 mg/ml) 15.0 ml and then incubated with shaking for certain time
at 55˚C, which was the optimum temperature for enzyme activities of Lipase AK. An in‐
creased degradation was observed as decreasing of the amount of PEG in soft segments of
WBPU, as judged from the change of tensile properties with time, owing to Lipase AK only
interacting with PCL soft segments in these polymers structures. This result reveals that the
degradation rate is proportional to the PCL content, and inverse proportion to the PEG con‐
tent in the WBPUs. Depending on the PCL content, degradation started even at 6 h in the
presence of Lipase AK.
A polyurethane was synthesized with LDI, PCL, and BD in the presence of dilaurate as cata‐
lyst by Han et al. (Han et al., 2009) and then degraded in PBS with a solution mixture includ‐
ing 4.0 mL PBS, 1.0 mL 0.1 wt.% MgCl2 and 1.0 mL Lipase AK (10 mg/mL) in water at 50˚C.
It was found that loss mass decreased with increasing the PCL soft segment content in hy‐
drolytic degradation in PBS. Because PCL is hydrophobic in comparison with the polar hard
segment, increasing its content would decrease water uptake of PU films, and then decrease
mass loss. In contrast, in the presence of Lipase AK the mass loss was observed to be in‐
creased with increasing the PCL soft segment content.
Biodegradable  polyurethanes  were  prepared  by  Wang  et  al.,  using  PLA-PEG-PLA  as
soft segment,  and L-lysine ethyl ester diisocyanate (LDI) and 1,4-butanediol (BD) as rig‐
id  segment  (Wang  et  al.,  2011b).  These  polymers  were  degraded  in  PBS  (0.1  M  PBS
with  0.9%  NaCl  and  0.02%  NaN3,  pH  7.4,  6  and  5)  and  enzymatic  (0.1mg/ml  lipase
from  porcine  pancreas  in  0.1  M  PBS  with  0.9%  NaCl  and  0.02%  NaN3,  pH  7.4)  solu‐
tions at  37 °C to simulate in  vivo  dynamic tissue environment.  PU samples demonstrat‐
ed  rapid  degradation  in  96  h  (more  than  90%)  which  might  be  attributed  to
hydrophilicity of  PEG segments,  low number-average molecular weight and microphase
separation  degree  of  these  polyurethanes  and  enzyme  functions.  The  enzymatic  degra‐
dation rate was higher than hydrolytic degradation rate, verifying that Lipase from por‐
cine pancreas can accelerate hydrolysis on these polyurethanes.
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A series of pH-sensitive biodegradable polyurethanes (pHPUs) were designed and synthe‐
sized using pH-sensitive macrodiol (poly(ε-caprolactone)-hydrazone-poly-(ethylene glycol)-
hydrazone-poly(ε-caprolactone) diol (PCL-Hyd-PEG-Hyd-PCL)), L-lysine ethyl ester
diisocyanate (LDI) and L-lysine derivative tripeptide as chain extender by Zhou et al. (Zhou
et al., 2011). The polyurethanes could be cleaved in acidic media (pH ∼ 4-6) as well as de‐
graded in PBS (100 mM, and pH 7.4) overnight at room temperature and enzymatic solution
(Lipase AK (10 mg/mL, 2 mL) in PBS buffer solution with 0.1 wt % MgCl2 (2 mL) and then
incubated with cyclic shaking at 52.5˚C). It was found that the hydrolysis rates of the two
samples observed in Lipase AK PBS are higher than that in PBS i.e. 31.1% and 35.9% of
weight loss are detected after hydrolytic and enzymatic degradation for 144 h of pHPU4
(pHPU prepared with LDI/macrodiol/tripeptide 3.15/2/1), respectively. The results indicate
that the pHPUs are also facile to degrade in enzymatic solution, which is in agreement with
reported literatures that Lipase AK is able to accelerate the PCL-based polymers biodegra‐
dation. Polymers with more pH sensitive macrodiol and lower crystallinity degraded even
faster. The importance of studying these materials (pH-sensitive biodegradable polyur‐
ethanes) lies in the fact that they been used for intracellular multifunctional antitumor drug
delivery (Zhou et al. 2012).
Elliott et al. (Elliott et al., 2002) determined mechanism of enzymatic degradation by
HPLC/MS. Prior to product separation and identification, residual enzyme (chymotrypsin)
was removed from the incubation solution samples. This process was necessary since the
chymotrypsin could interfere with the accurate detection of the degradation products in the
high performance liquid chromatography (HPLC) columns, and because proteins have a
tendency to aggregate and then later precipitate during the gradient run, thereby causing
additional difficulties in data acquisition. The results of the tandem mass spectrometry
(MS/MS) analysis indicated that chymotrypsin may act to cleave urea bonds adjacent to L-
phenylalanine residues. This is a significant finding since it confirms that the polyurethanes
are susceptible to selective enzymatic degradation in the hard segment. Traditionally, this
domain of the polyurethane has been considered a relatively stable group. The materials
used in this study, however, were especially developed to encourage degradation of the
hard segment rather than relying solely on degradation of the soft segment. Hence, the re‐
sults of this study confirm that this goal was achieved. The cleavage of urea bonds by chy‐
motrypsin is an important finding as it contradicts results of a previous study with similar
chemistry that found that urea bonds adjacent to L-phenylalanine residues were not
cleaved. However, since the level of chymotrypsin activity was not stated in the other study,
it may be possible that the right conditions were not presented in order to degrade the urea
bond (Elliott et al., 2002).
4.5. Lipid degradation
Lipid absorption has been reported to occur in many medical devices such as heart valves
made of silicon, leading to their calcification. In addition, fatigue properties of SPU have
been reduced by lipid absorption.
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Takahara et al. (Takahara et al., 1992) degraded SPU´s based on MDI, BD and various poly‐
ols using 0.25 % phophatidyl choline and 0.1% M cholesterol liposome solution during 28
days at 37°C. They found that SPU based on PDMS disintegrated under these conditions
while PTMO based SPUs exhibited a severe reduction in tensile strength and elongation.
These results were not related to the presence of a specific chemical group in the soft seg‐
ment as PEO based SPU´s were not affected.
4.6. Compost biodegradation
Synthetic poly(ester urethanes) are known to be degraded by microbes mainly due to the
presence of ester linkages, being more susceptible those containing long chains rather than
short polyester chains. Lactic acid based polyester urethanes have been degraded with com‐
post inoculum (thermophilic-stage household waste compost was added to 100 ml of ASTM
solution and the CO2 evolved was followed by Hiltunen et al. (Hiltunen et al., 1997). The
data showed that poly(ester-urethanes) did not biodegrade at 25˚C but when the tempera‐
ture was raised, biodegradation was accelerated. At 37°C the stereo structure of polymer
chains had a strong effect on biodegradation. This temperature was below the glass transi‐
tion temperature of poly(ester-urethanes) but about the same as the glass transition temper‐
ature of prepolymer chains. The lower the glass transition temperature of prepolymer, the
faster the biodegradation. Urethane bonds probably break first, and after that the properties
of lactic acid prepolymer chains determine the biodegradation behavior. All poly(ester-ure‐
thane) samples biodegraded well at 55°C, and the percentage of biodegradation varied be‐
tween 45 and 77% in 55 days. At 60°C the poly(ester-urethanes) biodegraded well and they
reached even higher levels of biodegradation than Biopac™ and lactic acid. The biodegrada‐
tion varied from 45 to 77% in 55 days.
Polyurethanes based on MDI and PCL with different molecular weights were prepared by
Watanabe et al. (Watanabe et al., 2009) and degraded by soil burial test at 28˚C. It was found
that biodegradation rate of the polyurethanes increased as the number of average molecular
weight (Mn) of poly(caprolactone) diol used increased from 500 to 1000 (urethane content
11.9 to 7.6 wt % respectively), whereas it decreased as the Mn of poly(caprolactone) diol in‐
creased from 1200 to 2000 (4.2 wt % of urethane content). Furthermore, when 2000 PCL triol
was used led to a high degradation ratio.
4.7. Thermal degradation of polyurethanes
Although  the  thermal  degradation  of  both  polyurethanes  (PU)  and  segmented  polyur‐
ethanes  (SPU)  has  been  extensively  investigated  due  to  their  wide  range  of  applica‐
tions,  studies  on  thermal  decomposition  of  polyurethanes  used  specifically  in
biomedical  field  such  as  catheters,  heart  valves,  vascular  prostheses,  etc.,  are  less  com‐
mon as generally these materials  are not subjected to high temperatures during their  in
vivo  performance [Cervantes-Uc et al.  2009].  In some cases,  these studies are used to in‐
vestigate  the  composition and stability  of  the  remaining material  after  the  chemical  hy‐
drolysis  and oxidation of  SPU [Chan-Chan et  al.  2010]  as  well  as  to  determine the soft
and hard segment ratio of  polyurethanes.
Advances in Biomaterials Science and Biomedical Applications70
The thermal degradation of polyurethanes allows determination of the proper conditions for
manipulating and processing them and for obtaining high-performance products that are
stable and free of undesirable by-products; if not processed properly, commonly by extru‐
sion or by injection moulding, the PU’s would generate toxic products to the human body,
which is very critical in biomedical applications [Gomes Lage et al. 2001].
It is well known that polyurethanes are not thermal stable polymers and that the onset deg‐
radation temperature of the urethane bond depends on the type of isocyanate and alcohol
used. It is a general rule that the more easily formed polyurethanes are less stable, i.e. more
easily dissociated when compared with more difficulty formed ones [Petrovic et al. 1994].
Petrovic reported that the degradation temperature for these materials ranged from 120°C to
250°C depending on their structure [Petrovic et al. 1994]; however, literature reports proc‐
essing temperatures closer to 180°C [Guignot 2002].
Polyurethanes are thermally degraded through three basic mechanisms. First, by urethane
bond dissociation into its starting components (isocyanate and alcohol); secondly, by break‐
ing the urethane bond with formation of primary amines, carbon dioxide and olefins; and
finally, splitting the urethane bond into secondary amine and carbon dioxide [Petrovic et al.
1994; Cervantes-Uc et al. 2009].
5. Degradation mechanism
The nature of PU chemistry is central to understand why some PUs undergo faster degrada‐
tion than others (Santerre et al., 2005). However, the degradation mechanism of polyur‐
ethanes depends on not only the PU chemistry structure but also the degradation
environment, i.e. in the presence of water, acidic, alkaline or oxidative conditions, or in the
presence of enzymes. Generally, the characterization of the by-products during the degrada‐
tion of the polyurethane is the key to understand the mechanisms of degradation. Identifica‐
tion of degradation products is an important issue but of equal interest is the eventual
toxicity of the degradation products. If the biomaterial degrades, either spontaneously or
due to biological activity, components can leach into surrounding tissues and cause an in‐
flammatory response if not easily metabolized by natural pathways. Therefore, it is compul‐
sory to identify the major species produced at different stages of degradation and the
kinetics of their formation (Azevedo et al., 2005).
Accelerated degradation has been used to determinate stability of non degradable polyur‐
ethanes (Gunatillake, 1992) but it can be used to provide valuable information about degra‐
dation mechanism of resorbable polyurethanes. In this context, both soluble products and
solid residues can be studied with different analytical techniques and tests to determine
their composition.
The main techniques used to evaluate the degradation of biomaterials can be divided into
surface analysis (infrared spectroscopy, X-ray photoelectron spectroscopy, contact angle
measurements), which are more appropriated to monitor the changes occurring in the first
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stages of degradation, and bulk analysis (determination of changes in molecular weight,
weight loss, temperature transitions, mechanical properties) for characterizing the later
stage of degradation (Azevedo et al., 2005).
In general, polyesterurethanes are susceptible to hydrolytic degradation because of ester
groups in the soft segments while polyetherurethanes are susceptible to oxidative degrada‐
tion. Furthermore, it has been observed that ester linkages hydrolyze about a magnitude
faster than urethane linkages, and it has been shown that urea linkages hydrolyze faster
than urethane, although at slightly acidic conditions. Figure 5 shows the possible mecha‐
nism of hydrolytic degradation of various functional groups present in polyurethanes.
Figure 5. Hydrolytic degradation mechanism of polyesters (A), poly(urethane) (B) and poly(ureas) (C).
In spite of this, the degradation rate of the poly(ester urethane) based on PCL was found to
be slow (i.e., 15% weight loss in 11 weeks (Wang et al., 2008). Furthermore, IR spectra for the
degradation products of the LDI/PCL and LDI (lysine methyl ester diisocyanate)/P6C3G1L
(triol synthesized from a glycerol starter and a mixture of monomers comprising 60% capro‐
lactone, 30% glycolide, and 10% DL-lactide) materials after 2 and 8 months in PBS (Guelcher
et al., 2008) shows an absorption band at approximately 1070-1050 cm-1, which is assigned to
C-O stretching vibrations in alcohols and carboxylic acids. This observation implies that the
polyurethanes degrade by hydrolysis of ester linkages to yield α-hydroxy acids and is fur‐
ther supported by the appearance of the strong peaks at 1675-1650 cm-1, which correspond
to the COO asymmetric stretching vibration associated with carboxylic acid salts. Therefore,
it is possible under these conditions that phosphate salts of carboxylic acids will form in the
PBS solution due to the reaction of carboxylic acids with the basic phosphate salts present in
PBS. Hydrolysis of LDI/PCL containing poyurethanes networks in sodium hydroxide solu‐
tions has been reported to yield L-lysine as a degradation product; however, the presence of
L-lysine in the degradation products under physiological conditions was not confirmed.
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Other studies reported the presence of lysine in the degradation products from lysine-de‐
rived polyurethanes networks.
Segmented polyurethane based on poly(ε-caprolactone), ethyl lysine diisocyanate or hexam‐
ethylene diisocyanate in combination with ethylene glycol or ester from ethylene glycol and
lactic acid (2-hydroxyethyl 2-hydroxypropanoate) with greater hard segment content (HS)
liberate higher amine concentrations during their degradation (Tatai et al., 2007). Amine
concentration was determined using a spectrophotometer by acquiring the A570 (absorbance
at 570 nm) of the test sample and by quantifying the detected concentration with use of the
standard curve. This being expected, on the assumptions that PUs with higher HS contained
more urethane bonds. To detect amine groups using this technique, a degradation product
must undergo hydrolysis at its respective urethane linkage. Since this process is somewhat
slower than that of ester bond hydrolysis, it seems that part of the degradation product may
still contain urethane segments.
Hafeman et al. (Hafeman et al., 2011) investigate the effects of esterolytic and oxidative con‐
ditions on scaffold degradation by incubating in 1 U/mL cholesterol esterase (CE), 1 U/mL
carboxyl esterase (CXE), and 10 U/mL lipase (L) hydrogen peroxide (20 wt% hydrogen per‐
oxide (H2O2) in 0.1 M cobalt chloride (CoCl2), and buffer alone (0.5 M monobasic sodium
phosphate buffer with 0.2% w/w sodium azide) and analysed the degradation products by
HPCL. Hydrolysis of ester bonds was anticipated to yield α-hydroxy acids (e.g., hydroxy‐
caproic, lactic, and glycolic acids), which was confirmed by HPLC. The lysine triisocyanate
(LTI) scaffolds produced more α-hydroxy acids than trimer of hexamethylene diisocyanate
(HDIt) scaffolds. The 7C/LTI (triol synthesized from a glycerol starter and a mixture of mon‐
omers comprising 70% caprolactone, 30% glycolide and 10% lactide) formulation, which de‐
graded more slowly due to the longer polyester half-life, yielded lower concentrations of α-
hydroxy acids than the 6C/LTI (60% caprolactone, 30% glycolide and 10% lactide)
formulation. Inclusion of polyethylene glycol (PEG) in the 6C/HDIt scaffold reduced the
amount of α-hydroxy acids in the degradation medium due to the replacement of 50% of the
polyester with PEG. Several unidentified peaks appeared in the HPLC spectra, which are
conjectured to be adducts of α-hydroxy acids and either lysine or ethanolamine connected
by urethane or urea bonds. Oxidation of urethane and urea bonds was predicted to yield ly‐
sine and ethanolamine from LTI scaffolds, and cyanuric acid from HDIt scaffolds. Both ly‐
sine and ethanolamine were detected in the degradation products from LTI scaffolds when
incubated in PBS; however, cyanuric acid was not detected in the degradation products
from HDIt scaffolds. The amount of lysine recovered from 6C/LTI scaffolds was significant‐
ly greater than that from 7C/LTI scaffolds after 14 weeks, which is consistent with the faster
in vitro degradation of the 6C/LTI materials. At 36 weeks, 18% of the lysine incorporated in
the 6C/LTI scaffolds was recovered, while 100% of the original mass had degraded to solu‐
ble degradation products. This suggests that the majority of the lysine was incorporated in
soluble urethane and urea adducts with α-hydroxy adducts. The recovery of ethanolamine
arises from the hydrolysis of the ester group in LTI and a urethane bond. Ethanolamine was
not detected (<0.001 μg/mg polyurethane) until 14 weeks, and at later time points the etha‐
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nolamine concentration increased with time. The recovery of ethanolamine upon complete
dissolution of the 6C/LTI scaffold at 36 weeks was 9%.
Suntherland et al. (Sutherland et al., 1993) degraded Pellethane 2363 80A with either HClO
or ONOO. An oxidative reaction involving the ether or ester moieties of PEU would be re‐
flected by a decrement in the urethane-aliphatic ester and/or aliphatic ether stretching peaks
on ATR/FTIR analysis. Indeed, a substantial decrement in the aliphatic ether stretching at
1105-1110 cm-1 relative to the urethane-aliphatic ester peak at 1075 cm-1 has been observed in
implanted material. In fact, the intensity of both aliphatic ether and urethane-aliphatic ester
peaks decreases after long-term implantation, suggesting that both groups are oxidized in
vivo. PEU previously exposed to HClO exhibited a decrement in the signal from the ure‐
thane-aliphatic ester.
FTIR has been used to determine the composition of residues after degradation. In this
sense, hydrolytic degradation of polyester urethanes affects carbonyl bands at 1730 cm-1.
Soluble products of the ester scission are carboxyl acids and alcohols that can be observed
between 2500 and 3500 cm-1. Pérez et al. (Pérez et al., 2006) studies showed that urea bonds
derived from amino acids can be hydrolyzed in basic conditions but after more prolonged
period than ester groups, this degradation was monitored by capillary electrophoresis-ion
trap-mass.
Oxidative degradation has been generally associated with poly(ether-urethane)s, since many
studies have determined that these polymers degrade by mean alpha-hydrogen abstraction
adjacent to oxygen in polyethers and polycarbonates (Christenson et al., 2004; Xie et al.,
2009). In contrast, few works related to oxidative degradations on polyester polyurethanes
has been done, and even less has studied the mechanism of degradation of polyurethane
ureas. However recent studies about oxidative degradations of PCL and polyester poly(ure‐
thane urea)s PCL based have showed ester, urethane and urea groups are susceptible to oxi‐
dative degradation (Sabino, 2007; Sarkar et al., 2007; Hafeman et al., 2011). This mechanism
is illustrated in Figure 6.
Figure 6. Mechanism of oxidative degradation by H2O2 in poly(ether urethanes) (A), poly(carbonate urethanes) (B)
and aromatic polyurethanes (C).
Oxidative degradation using HClO is less commonly pursued but it may be clinically more
relevant as hipochlorous anions can be produced by neutrophils. These conditions can be si‐
mulated in vitro and the suggested mechanisms of the polyurethane degradation can be de‐
picted in Figure 7.
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Figure 7. Mechanism of oxidative degradation in polyurethanes by means of HClO
Degradation of polyurethanes with H2O2 (30% v/v) does not seem to affect ester bonds but
affect urea bonds as observed by FTIR. The wide band of 3650-3400 cm-1 and a small peak in
930 cm-1 corresponding to carboxylic acid confirm scission of urea groups as shown in Fig‐
ure 8. Other bands such as those at 1298 cm-1 show some crosslinking by C-N bonds and an
increase in PCL crystallinity, as the 1143 y 1189 cm-1 bands, corresponding to amorphous
and crystalline PCL, changed (Chan-Chan, 2012).
Figure 8. FTIR spectra of poly(urethane ureas) degraded in various media.
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6. Conclusions
Polyurethanes are very versatile polymers that found application in the biomedical field, es‐
pecially in cardiovascular applications. In spite of their good physicochemical and mechani‐
cal properties and acceptable biocompatibility they are prone to degradation under different
conditions. These conditions range from hydrolysis, oxidation, metal induced oxidation, en‐
vironmental stress cracking, enzyme-assisted degradation, etc. which can be found in vivo
during the useful life of the device. In order to simulate these, in vitro approaches has been
followed. Thanks to this information today it is well accepted that polyurethanes are no lon‐
ger inert materials placed within the body. However, this disadvantage can be used to mod‐
ulate their degradation to a rate that can be controlled mainly by their composition, and be
used in the design of tissue engineering scaffolds.
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